| Group A | Group B | p-value | ||
---|---|---|---|---|---|
Variables | (n = 7) | (n = 8) | |||
Age (average ± SD) | 49.3 ± 16.9 | 59.0 ± 21.9 | 0.22 | ||
FIGO stage (%) | Â | Â | Â | Â | 0.99 |
I | 5 | (71.4) | 6 | (75.0) | Â |
II | 0 | (0.0) | 1 | (12.5) | Â |
III | 1 | (14.3) | 0 | (0.0) | Â |
IV | 1 | (14.3) | 1 | (12.5) | Â |
Residual tumor after primary surgery (%) | Â | Â | Â | Â | 0.57 |
Yes | 2 | (28.6) | 1 | (12.5) | Â |
No | 5 | (71.4) | 7 | (87.5) | Â |
Peritoneal cytology (%) | Â | Â | Â | Â | 0.19 |
Positive | 4 | (57.1) | 1 | (12.5) | Â |
Negative | 3 | (42.9) | 7 | (87.5) | Â |
Endometriosis (%) | Â | Â | Â | Â | 0.19 |
Yes | 4 | (57.1) | 1 | (12.5) | Â |
No | 3 | (42.9) | 7 | (87.5) | Â |
Recurrence (%) |  |  |  |  | < 0.01 |
Yes | 5 | (71.4) | 0 | (0.0) | Â |
No | 2 | (28.6) | 8 | (100.0) | Â |
Died of disease (%) | Â | Â | Â | Â | 0.03 |
Yes | 4 | (57.1) | 0 | (0.0) | Â |
No | 3 | (42.9) | 8 | (100.0) | Â |